Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to ease Cyberbullying's toll on teens

NCT ID NCT04176666

Symptom relief Sponsor: University of Tromso Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a mobile app called NettOpp for teens aged 11-16 who experienced cyberbullying. The app was designed to be a free, low-threshold support tool. Researchers measured mental health, trauma symptoms, and well-being in 709 participants across Norway.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NettOpp mobile application
What this could lead to
If it works, this could provide a free, easy-to-use tool to help teens feel better after cyberbullying.
What could go wrong
This is a completed study, but results may not apply outside Norway. The app is not a cure and only aims to ease symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

709 people

The number who actually took part.

Started

Sep 2021

Finished

Jul 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

11 to 16 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adolescents whose guardians have given consent and who agree to take part in the study Exclusion Criteria: * severe developmental or cognitive challenges

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cyberbullying are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cyberbullying

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cyberbullying

Contacts and locations

Locations

  • UiT The Arctic University of Norway

    Tromsø, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.